Advertisement

Pädiatrie pp 1117-1123 | Cite as

Herzinsuffizienz und Hypoxämie

  • H. H. Kramer

Zusammenfassung

Eine Herzinsuffizienz liegt vor, wenn das Herz nicht in der Lage ist, ein für den metabolischen Bedarf des Organismus ausreichendes Herzminutenvolumen zu fördern.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Benitz WE, Malachowski N, Cohen RS, Stevenson DK, Ariagno RL, Sunshine P (1985) Use of sodium nitroprusside in neonates: efficacy and safety. J Pediatr 106:102–110PubMedCrossRefGoogle Scholar
  2. Brunner HR, Nussberger J, Waeber B (1994) Dose-response relationship of ACE inhibitors and angiotensin II blockers. Eur Heart J 15 (Suppl D): 123–128PubMedCrossRefGoogle Scholar
  3. Buchhorn R, Bartmus D, Siekmeyer W et al. (1998) Betablocker therapy of severe congestive heart failure in infants with left to rigt shunts. Am J Cardiol 148: 1366–1368CrossRefGoogle Scholar
  4. Cohn JN (1993) Efficacy of vasodilators in the treatment of heart failure. JACC 22 (Suppl A): 135A–138APubMedCrossRefGoogle Scholar
  5. Colucci WS, Wright RF, Braunwald E (1986a) New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments (part 1). N Engl J Med 314: 290–299PubMedCrossRefGoogle Scholar
  6. Colucci, WS, Wright, RF, Braunwald, E (1986b) New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments (part 2). N Engl J Med 314: 349–358PubMedCrossRefGoogle Scholar
  7. Deutsche Gesellschaft für Pädiatrische Kardiologie (Hrsg) (1998) Leitlinien zur rationalen Diagnostik und Therapie von Erkrankungen des Herzens und des Kreislaufs bei Kindern und Jugendlichen. Steinkopff, DarmstadtGoogle Scholar
  8. Garg R, Yusuf S for the Collaborative Group on the ACE Inhibitor Trials (1995) Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 273: 1450–1456PubMedCrossRefGoogle Scholar
  9. Hsu DT, Quaegebeur JM, Michler RE, Smith CR, Rose EA, Kichuk MR, Gersony WM, Douglas JF, Addonizio LJ (1995) Heart transplantation in children with congenital heart disease. JACC26/3: 743–749PubMedCrossRefGoogle Scholar
  10. Jayais P, Mauriat P, Pouard P, Journois D (1990) Enoximone et chirurgie cardiaque pediatrique. Arch Mal Coeur 83/111: 109–117PubMedGoogle Scholar
  11. Kelly RA, Smith TW (1993) Digoxin in heart failure: Implications of recent trials. JACC (Suppl A): 107A–112AGoogle Scholar
  12. Koren G (1985) Interaction between digoxin and commonly coadministered drugs in children. Pediatrics 75: 1032–1037PubMedGoogle Scholar
  13. Kramer HH (1998) Herzinsuffizienz. In: Deutsche Gesellschaft für Pädiatrische Kardiologie (Hrsg) Leitlinien zur rationalen Diagnostik und Therapie von Erkrankungen des Herzens und des Kreislaufs bei Kindern und Jugendlichen. Steinkopff, Darmstadt, S 27–33Google Scholar
  14. Kramer HH (2003) Herzinsuffizienz. In: Reinhardt D (Hrsg) Therapie der Krankheiten des Kindesalters, 7. Aufl. Springer, Berlin Heidelberg New York, in VorbereitungGoogle Scholar
  15. Packer M (1992) Pathophysiology of chron heart failure. Treatment of chronic heart failure. Lancet 340: 88–95PubMedCrossRefGoogle Scholar
  16. Park MK (1986) Use of digoxin in infants and children with specific emphasis on dosage. J Pediatr 108: 871–877PubMedCrossRefGoogle Scholar
  17. Reid JL, MacFadyen RJ, Squire IB, Lees KR (1993) Angiotensin-converting enzyme inhibitors in heart failure: blood pressure changes after the first dose. Am Heart J 126: 794–797PubMedCrossRefGoogle Scholar
  18. Taylor SH (1985) Diuretics in cardiovascular therapy. Perusing the past, practising in the present, preparing for the future. Z Kardiol 74 (Suppl2): 2–12PubMedGoogle Scholar
  19. Witte, MK, Stork, JE, Blumer, JL (1986) Diuretic therapeutics in the pediatric patient. Am J Cardiol 57: 44A–53APubMedCrossRefGoogle Scholar
  20. Zaritsky, A, Chernow, B (1984) Use of catecholamines in pediatrics. J Pediatr 105: 341–350PubMedCrossRefGoogle Scholar
  21. Beekman RH, Tuuri DT (1985) Acute hemodynamic effects of increasing hemoglobin concentration in children with a right to left ventricular shunt and relative anemia. J Am Coll Cardiol 15: 357–362CrossRefGoogle Scholar
  22. Nadas AS (1992) Hypoxemia. In: Fyler DC (ed) Nadas‘ Pediatric Cardiology. Hanley & Belfus, Philadelphia, pp 73–76Google Scholar
  23. Paridon SM (1990) Consequences of chronic hypoxemia and pulmonary vascular resistance. In: A Garson, JT Bricker, McNamara DG (eds) The Science and Practice of Peditatric Cardiology. Lea & Febiger, Philadelphia London, pp 1996–2006Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • H. H. Kramer

There are no affiliations available

Personalised recommendations